Maynard Um
-
-
-
-
-
-
-
Roivant Sciences (ROIV) Reiterated at Overweight by JPMorgan on Lisraya Feedback
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Roivant Sciences (ROIV)
-
-
-
-
-
-
-
Roivant Sciences (ROIV) PT Raised at TD Cowen as 'IMVT-1402 Shines In D2T RA'
-
-
-
-
-
-
-
Bernstein SocGen Group Starts Roivant Sciences (ROIV) at Outperform
-
-
-
-
-
-
-
Roivant Sciences (ROIV) PT Raised to $33 at H.C. Wainwright
-
-
-
-
-
-
-
Roivant Sciences (ROIV) PT Raised to $32 at Leerink Partners
-
-
-
-
-
-
-
Roivant Sciences (ROIV) call put ratio 12 calls to 1 put with a focus on December 20 and January 16 calls
-
470,361 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


